Eurizon Capital SGR S.p.A. Makes New $47.21 Million Investment in Corteva, Inc. $CTVA

Eurizon Capital SGR S.p.A. bought a new position in shares of Corteva, Inc. (NYSE:CTVA) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 704,242 shares of the company’s stock, valued at approximately $47,206,000.

Other hedge funds also recently bought and sold shares of the company. JPL Wealth Management LLC purchased a new stake in Corteva during the third quarter worth $25,000. Redmont Wealth Advisors LLC purchased a new stake in Corteva during the third quarter worth $29,000. Jackson Grant Investment Advisers Inc. lifted its holdings in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after buying an additional 213 shares during the period. Basepoint Wealth LLC purchased a new stake in Corteva during the fourth quarter worth $30,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Corteva during the third quarter worth $33,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE CTVA opened at $78.41 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock’s fifty day moving average price is $81.33 and its 200 day moving average price is $74.53. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The company has a market cap of $52.44 billion, a price-to-earnings ratio of 46.12, a PEG ratio of 2.39 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm earned $1.13 EPS. The firm’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Ratings Changes

A number of analysts have weighed in on CTVA shares. BNP Paribas Exane upped their target price on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and upped their price target for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Berenberg Bank upped their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. CICC Research upped their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, Argus upped their price target on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.